Literature DB >> 18488216

Preoperative chemotherapy for soft tissue sarcomas: reinventing the wheel.

Gerald Rosen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18488216     DOI： 10.1007/s00256-008-0509-5

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  12 in total

1.  Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.

Authors:  F C Eilber; G Rosen; J Eckardt; C Forscher; S D Nelson; M Selch; F Dorey; F R Eilber
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 44.544

2.  Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate.

Authors:  A S Gelbard; R S Benua; J S Laughlin; G Rosen; R E Reiman; J M McDonald
Journal:  J Nucl Med       Date:  1979-07       Impact factor: 10.057

3.  Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.

Authors:  G Rosen; A Nirenberg
Journal:  Cancer Treat Rep       Date:  1982-09

4.  The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma.

Authors:  Fritz C Eilber; Frederick R Eilber; Jeffery Eckardt; Gerald Rosen; Elyn Riedel; Robert G Maki; Murray F Brennan; Samuel Singer
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

5.  Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.

Authors:  A G Huvos; G Rosen; R C Marcove
Journal:  Arch Pathol Lab Med       Date:  1977-01       Impact factor: 5.534

6.  Synovial sarcoma. A study of intensive chemotherapy in 14 patients with localized disease.

Authors:  C E Kampe; G Rosen; F Eilber; J Eckardt; S Lowenbraun; J Foster; C Forscher; M Selch
Journal:  Cancer       Date:  1993-10-01       Impact factor: 6.860

7.  Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma.

Authors:  Fritz C Eilber; Murray F Brennan; Frederick R Eilber; Jeffery J Eckardt; Stephen R Grobmyer; Elyn Riedel; Charles Forscher; Robert G Maki; Samuel Singer
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

8.  Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

Authors:  G Rosen; B Caparros; A G Huvos; C Kosloff; A Nirenberg; A Cacavio; R C Marcove; J M Lane; B Mehta; C Urban
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

9.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

Review 10.  Preoperative therapy for soft tissue sarcoma.

Authors:  F Eilber; J Eckardt; G Rosen; C Forscher; M Selch; Y S Fu
Journal:  Hematol Oncol Clin North Am       Date:  1995-08       Impact factor: 3.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.